Ghrelin regulates sepsis‑induced rat acute gastric injury

Li,Bin; Lin,Qingling; Guo,Hong; Liu,Liping; Li,Yumin

doi:10.3892/mmr.2019.10208

Ghrelin regulates sepsis‑induced rat acute gastric injury

Authors:
- Bin Li
- Qingling Lin
- Hong Guo
- Liping Liu
- Yumin Li
View Affiliations

Affiliations: Department of General Surgery, The Second Hospital of Lanzhou University, Lanzhou, Gansu 730000, P.R. China, Department of Intensive Medicine, The First Hospital of Lanzhou University, Lanzhou, Gansu 730000, P.R. China
Published online on: April 30, 2019 https://doi.org/10.3892/mmr.2019.10208
Pages: 5424-5432
Copyright: © Li et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Ghrelin, a peptide expressed in the gastric mucosa, has an essential role in sustaining the normal function of the digestive system. Sepsis is one of the primary causes of mortality in intensive care units and can lead to multiple organ dysfunction, especially in the gastrointestinal system. The aim of the present study was to explore the effect of ghrelin on gastric blood flow in a rat model of sepsis, as well as the effect of ghrelin on the expression of the apoptotic markers, B‑cell lymphoma 2 (Bcl‑2) and Bcl‑2‑associated X (Bax), in gastric tissues. The sepsis model was established using cecal ligation and puncture (CLP). The expression levels of apoptosis‑related factors in gastric epithelial cell were determined by immunohistochemistry, reverse transcription quantitative‑PCR and western blotting. Collectively, the present results suggested that ghrelin administration attenuated sepsis symptoms induced by CLP. Blood flow in the stomach greater curvature was significantly higher in the CLP‑induced sepsis group rats (284.3±95.7 perfusion units) compared with the sham operation group (317.8±5.2 perfusion units; P<0.05), whereas there was no difference between the CLP group treated with ghrelin (377.8±99.0 perfusion units) and the sham rats. Ghrelin administration also reduced the secretion of pro‑inflammatory cytokines compared with the CLP‑induced sepsis group rats. In addition, CLP significantly reduced the expression of Bcl‑2 and enhanced the expression of the pro‑apoptotic proteins, Bax and cleaved caspase‑3; whereas, ghrelin application reversed the effects of CLP on these apoptosis‑associated proteins. In conclusion, the present study revealed that ghrelin has the ability to increase blood flow in the gastrointestinal tract in a sepsis model and can also regulate the expressions of apoptosis‑associated factors in gastric tissues. These results suggest that ghrelin could be a novel treatment for sepsis‑induced gastric injury.

View Figures

View References

1	Lever A and Mackenzie I: Sepsis: Definition, epidemiology, and diagnosis. BMJ. 335:879–83. 2007. View Article : Google Scholar : PubMed/NCBI
2	Martin GS: Sepsis, severe sepsis and septic shock: Changes in incidence, pathogens and outcomes. Expert Rev Anti Infect Ther. 10:701–706. 2012. View Article : Google Scholar : PubMed/NCBI
3	Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, Bellomo R, Bernard GR, Chiche JD, Coopersmith CM, et al: The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 315:801–810. 2016. View Article : Google Scholar : PubMed/NCBI
4	Kennelly PJ and Martin-Loeches I: Long term mortality following sepsis. Ann Transl Med. 4:3872016. View Article : Google Scholar : PubMed/NCBI
5	Lang CH, Bagby GJ, Ferguson JL and Spitzer J: Cardiac output and redistribution of organ blood flow in hypermetabolic sepsis. Am J Physiol. 246:R331–R337. 1984.PubMed/NCBI
6	Moore JX, Donnelly JP, Griffin R, Howard G, Safford MM and Wang HE: Defining sepsis mortality clusters in the united states. Crit Care Med. 44:1380–1387. 2016. View Article : Google Scholar : PubMed/NCBI
7	Dashwood AM, Mason R, Jennings C and Dhillon P: Hepatic portal venous gas with associated bowel ischaemia and intra-abdominal sepsis after recent chemotherapy. BMJ Case Rep. 2016(pii): bcr2015213562016.
8	Zhang T, Yang J, Ding C, Li Y, Gu L, Wei Y, Cao L, Gong J, Zhu W, Li N and Li J: Preoperative intra-abdominal sepsis, not penetrating behavior itself, is associated with worse postoperative outcome after bowel resection for crohn disease: A Retrospective Cohort Study. Medicine (Baltimore). 94:e19872015. View Article : Google Scholar : PubMed/NCBI
9	Hiltebrand LB, Krejci V, tenHoevel ME, Banic A and Sigurdsson GH: Redistribution of microcirculatory blood flow within the intestinal wall during sepsis and general anesthesia. Anesthesiology. 98:658–669. 2003. View Article : Google Scholar : PubMed/NCBI
10	Albanèse J, Leone M, Delmas A and Martin C: Terlipressin or norepinephrine in hyperdynamic septic shock: A prospective, randomized study. Crit Care Med. 33:1897–1902. 2005. View Article : Google Scholar : PubMed/NCBI
11	Patel BM, Chittock DR, Russell JA and Walley KR: Beneficial effects of short-term vasopressin infusion during severe septic shock. Anesthesiology. 96:576–582. 2002. View Article : Google Scholar : PubMed/NCBI
12	van Haren FM, Rozendaal FW and van der Hoeven JG: The effect of vasopressin on gastric perfusion in catecholamine-dependent patients in septic shock. Chest. 124:2256–2260. 2003. View Article : Google Scholar : PubMed/NCBI
13	Janiuk I, Kaleczyc J and Kasacka I: Ghrelin-immunoreactive cells in the gastrointestinal tract of hypertensive rats. Folia Histochem Cytobiol. 54:181–185. 2016. View Article : Google Scholar : PubMed/NCBI
14	Sakata I, Nakamura K, Yamazaki M, Matsubara M, Hayashi Y, Kangawa K and Sakai T: Ghrelin-producing cells exist as two types of cells, closed- and opened-type cells, in the rat gastrointestinal tract. Peptides. 23:531–536. 2002. View Article : Google Scholar : PubMed/NCBI
15	Sakata I and Sakai T: Ghrelin cells in the gastrointestinal tract. Int J Pept. 2010(pii): 9450562010.PubMed/NCBI
16	Shao Y, Liu S, Tang X, Gao J, Wu G and Li Z: Ontogeny of ghrelin mRNA expression and identification of ghrelin-immunopositive cells in the gastrointestinal tract of the Peking duck, Anas platyrhynchos. Gen Comp Endocrinol. 166:12–18. 2010. View Article : Google Scholar : PubMed/NCBI
17	Wang JX, Peng KM, Liu H, Song H, Chen X and Liu M: Distribution and developmental changes in ghrelin-immunopositive cells in the gastrointestinal tract of African ostrich chicks. Regul Pept. 154:97–101. 2009. View Article : Google Scholar : PubMed/NCBI
18	Kaplan RC, Strizich G, Aneke-Nash C, Dominguez-Islas C, Bůžková P, Strickler H, Rohan T, Pollak M, Kuller L, Kizer JR, et al: Insulinlike growth factor binding protein-1 and ghrelin predict health outcomes among older adults: Cardiovascular Health Study Cohort. J Clin Endocrinol Metab. 102:267–278. 2017.PubMed/NCBI
19	Mansson JV, Alves FD, Biolo A and Souza GC: Use of ghrelin in cachexia syndrome: A systematic review of clinical trials. Nutr Rev. 74:659–669. 2016. View Article : Google Scholar : PubMed/NCBI
20	Sominsky L, Ziko I, Nguyen TX, Andrews ZB and Spencer SJ: Early life disruption to the ghrelin system with over-eating is resolved in adulthood in male rats. Neuropharmacology. 113:21–30. 2017. View Article : Google Scholar : PubMed/NCBI
21	Zhou D, Jiang X, Jian W, Zheng L, Lu L and Zheng C: Comparing the effectiveness of total gastrectomy and gastric bypass on glucose metabolism in diabetic rats. Obes Surg. 26:119–125. 2016. View Article : Google Scholar : PubMed/NCBI
22	Konturek PC, Brzozowski T, Pajdo R, Nikiforuk A, Kwiecien S, Harsch I, Drozdowicz D, Hahn EG and Konturek SJ: Ghrelin-a new gastroprotective factor in gastric mucosa. J Physiol Pharmacol. 55:325–336. 2004.PubMed/NCBI
23	Bilgin HM, Tumer C, Diken H, Kelle M and Sermet A: Role of ghrelin in the regulation of gastric acid secretion involving nitrergic mechanisms in rats. Physiol Res. 57:563–568. 2008.PubMed/NCBI
24	Park JM, Kakimoto T, Kuroki T, Shiraishi R, Fujise T, Iwakiri R and Fujimoto K: Suppression of intestinal mucosal apoptosis by ghrelin in fasting rats. Exp Biol Med (Maywood). 233:48–56. 2008. View Article : Google Scholar : PubMed/NCBI
25	Wei C, Louis H, Schmitt M, Albuisson E, Orlowski S, Levy B and Kimmoun A: Effects of low doses of esmolol on cardiac and vascular function in experimental septic shock. Criti Care. 20:4072016. View Article : Google Scholar
26	Chen YK, Xu YK, Zhang H, Yin JT, Fan X, Liu DD, Fu HY and Wan B: Emodin alleviates jejunum injury in rats with sepsis by inhibiting inflammation response. Biomed Pharmacother. 84:1001–1007. 2016. View Article : Google Scholar : PubMed/NCBI
27	Kouno T, Akiyama N, Fujieda K, Nanchi I, Okuda T, Iwasaki T, Oka S and Yukioka H: Reduced intake of carbohydrate prevents the development of obesity and impaired glucose metabolism in ghrelin O-acyltransferase knockout mice. Peptides. 86:145–152. 2016. View Article : Google Scholar : PubMed/NCBI
28	Miyatake Y, Shiuchi T, Mawatari K, Toda S, Taniguchi Y, Futami A, Sato F, Kuroda M, Sebe M, Tsutsumi R, et al: Intracerebroventricular injection of ghrelin decreases wheel running activity in rats. Peptides. 87:12–19. 2017. View Article : Google Scholar : PubMed/NCBI
29	Zavros Y, Van Antwerp M and Merchant JL: Use of flow cytometry to quantify mouse gastric epithelial cell populations. Dig Dis Sci. 45:1192–1199. 2000. View Article : Google Scholar : PubMed/NCBI
30	Zeineldin M and Neufeld K: Isolation of epithelial cells from mouse gastrointestinal tract for western blot or RNA analysis. Bio Protoc. 2:e2922012. View Article : Google Scholar : PubMed/NCBI
31	Wu R, Dong W, Zhou M, Zhang F, Marini CP, Ravikumar TS and Wang P: Ghrelin attenuates sepsis-induced acute lung injury and mortality in rats. Am J Respir Crit Care Med. 176:805–813. 2007. View Article : Google Scholar : PubMed/NCBI
32	Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H and Kangawa K: Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature. 402:656–660. 1999. View Article : Google Scholar : PubMed/NCBI
33	Shirshev SV, Nekrasova IV, Orlova EG and Gorbunova OL: Roles of leptin and ghrelin in the regulation of the phenotype and cytokine production by NK cells from peripheral blood. Dokl Biol Sci. 470:249–252. 2016. View Article : Google Scholar : PubMed/NCBI
34	Wan SX, Shi B, Lou XL, Liu JQ, MA GG, Liang DY and Ma S: Ghrelin protects small intestinal epithelium against sepsis-induced injury by enhancing the autophagy of intestinal epithelial cells. Biomed Pharmacother. 83:1315–1320. 2016. View Article : Google Scholar : PubMed/NCBI
35	Wu R, Dong W, Zhou M, Cui X, Hank Simms H and Wang P: Ghrelin improves tissue perfusion in severe sepsis via downregulation of endothelin-1. Cardiovasc Res. 68:318–326. 2005. View Article : Google Scholar : PubMed/NCBI
36	Jacob A, Wu R, Zhou M, Coppa GF and Wang P: Mechanism of the inhibitory effect of ghrelin in sepsis. Hepat Med. 2:33–38. 2010.PubMed/NCBI
37	Pradhan G, Samson SL and Sun YX: Ghrelin: Much more than a hunger hormone. Curr Opin Clin Nutr Metab Care. 16:619–624. 2013. View Article : Google Scholar : PubMed/NCBI
38	Diz-Chaves Y: Ghrelin, appetite regulation, and food reward: Interaction with chronic stress. Int J Pept. 2011:8984502011. View Article : Google Scholar : PubMed/NCBI
39	Ariyasu H, Takaya K, Tagami T, Ogawa Y, Hosoda K, Akamizu T, Suda M, Koh T, Natsui K, Toyooka S, et al: Stomach is a major source of circulating ghrelin, and feeding state determines plasma ghrelin-like immunoreactivity levels in humans. J Clin Endocrinol Metab. 86:4753–4758. 2001. View Article : Google Scholar : PubMed/NCBI
40	Yorulmaz H, Ozkok E, Ates G, Aksu A, Balkıs N and Tamer S: Ghrelin: Impact on muscle energy metabolism in sepsis. Int J Pept Res Ther. 24:259–264. 2018. View Article : Google Scholar
41	Lyra Junior HF, Rodrigues IK, Schiavon LL and D Acâmpora AJ: Ghrelin and gastrointestinal wound healing. A new perspective for colorectal surgery. Acta Cir Bras. 33:282–294. 2018. View Article : Google Scholar : PubMed/NCBI
42	Czabotar PE, Lessene G, Strasser A and Adams JM: Control of apoptosis by the BCL-2 protein family: Implications for physiology and therapy. Nat Rev Mol Cell Biol. 15:49–63. 2014. View Article : Google Scholar : PubMed/NCBI
43	Tsujimoto Y: Role of Bcl-2 family proteins in apoptosis: Apoptosomes or mitochondria? Genes Cells. 3:697–707. 1998. View Article : Google Scholar : PubMed/NCBI
44	An HM, Tan YL, Shi J, Wang Z, Lv MH, Soares JC, Zhou D, Yang F and Zhang XY: Ginkgo biloba leaf extract and alpha-tocopherol attenuate haloperidol-induced orofacial dyskinesia in rats: Possible implication of antiapoptotic mechanisms by preventing Bcl-2 decrease and Bax elevation. Phytomedicine. 23:1653–1660. 2016. View Article : Google Scholar : PubMed/NCBI
45	Jiang Z, Liu X, Chang K, Liu X and Xiong J: Allyl Isothiocyanate inhibits the proliferation of renal carcinoma cell line GRC-1 by inducing an imbalance between Bcl2 and Bax. Med Sci Monit. 22:4283–4288. 2016. View Article : Google Scholar : PubMed/NCBI
46	Yorulmaz H, Ozkok E, Erguven M, Ates G, Aydin I and Tamer S: Effect of simvastatin on mitochondrial enzyme activities, ghrelin, hypoxia-inducible factor 1α in hepatic tissue during early phase of sepsis. Int J Clin Exp Med. 8:3640–3650. 2015.PubMed/NCBI